Identifying immune biomarkers of response to chemotherapy in malignant mesothelioma

Project Details

StatusFinished
Effective start/end date1/01/181/12/20

Funding

  • Insurance & Care NSW (icare): AUD11,646.00
  • Insurance & Care NSW (icare): AUD139,756.00
  • Insurance & Care NSW (icare): AUD69,878.00
  • Insurance & Care NSW (icare): AUD11,646.00